The Australian Securities Exchange (ASX) will adjust its key indexes in March 2025. This rebalancing is part of the exchange's periodic review process, designed to ensure that its indexes remain representative of the evolving market landscape. The changes will affect a range of indexes, including the S&P/ASX 200, S&P/ASX 300, and other sector-specific benchmarks. The rebalancing occurs every March, June, September and December quarter.
Investors in index funds or ETFs that track the S&P/ASX 200 or S&P/ASX 300 may see underlying changes in their portfolios as fund managers adjust holdings to reflect the new index composition. This could lead to buying or selling activity in the affected stocks, potentially impacting short term prices.
The rebalancing may create opportunities for investors to reallocate their portfolios based on the new sector weightings.
More specifically, the upcoming changes as listed highlight potential opportunities.
Sigma has only recently finalised the Chemist Warehouse merger.
Given the current market weakness, the move provides a buying opportunity to accumulate shares in this company.
Fund managers have no doubt already factored in this adjustment but further upside in PME and SIG is more likely than for MIN and RHC.
Changes will take place on March 24 2025. Check on the complete list at Market Index.